Equity Overview
Price & Market Data
Price: $4.94
Daily Change: +$0.59 / 11.94%
Daily Range: $4.03 - $4.95
Market Cap: $232,199,984
Daily Volume: 457,247
Performance Metrics
1 Week: -3.98%
1 Month: -17.80%
3 Months: -27.55%
6 Months: -55.53%
1 Year: 17.93%
YTD: -48.02%
Company Details
Employees: 173
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.